New possibilities 
in drug delivery

New possibilities in drug delivery

New possibilities 
in drug delivery
Leigh Spielberg
Leigh Spielberg
Published: Monday, April 1, 2019
Drug Delivery for the Retina & Posterior Segment Disease
“Drug delivery systems are in the forefront of research,” starts the foreword of this 500-page research compilation. Drug Delivery for the Retina & Posterior Segment Disease assembles and analyses recent advances in the research and development of these delivery systems, with an emphasis on implantable devices, iontophoresis and micro- and nanoparticles. This is a highly detailed text. The average chapters have between 50 and 100 references to recent publications. “Penetration Routes to Retina and Posterior Segment” provides a nifty introduction to the possibilities, while chapters on liposomes, colloidal carrier systems, lipid prodrugs and thermoresponsive gel systems open a new world of possibilities. This text is intended for researchers working on drug delivery routes and systems for the posterior segment and retina. Retinal specialists interested in keeping abreast of recent developments might also consider keeping this book handy as a reference work.
Tags: retina
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...